サマリー

めまい治療薬の世界市場 2023-2027
めまい治療薬市場は2022〜2027年に5億5,142万米ドル成長し、予測期間中のCAGRは5.58%で加速すると予測されます。当レポートでは、めまい治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場は、新興国におけるめまい治療薬の需要増加、発展途上国における医療施設の増加、オンラインチャネルの浸透の増加が牽引しています。
Technavioのめまい治療薬市場は以下のように区分されます：
タイプ別
- 末梢性めまい
- 中枢性めまい
流通チャネル別
- オフライン
- オンライン
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、めまいにおけるデジタルヘルスソリューションの統合が、今後数年間のめまい治療薬市場の成長を促進する主要な理由の1つであると特定している。また、新しいめまい治療薬の発売や製薬会社によるR&Dの増加は、市場の大きな需要につながるでしょう。
本レポートでは、めまい治療薬市場について以下の分野をカバーしています：
- めまい治療薬市場のサイジング
- めまい治療薬市場予測
- めまい治療薬市場産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上させるために設計されており、これに沿って、本レポートでは、AdvaCare Pharma、Altamira Therapeutics Ltd.、Amneal Pharmaceuticals Inc.、Endo International Plc、Epic Pharma LLC、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Ltd.などのめまい治療薬市場の主要ベンダーの詳細な分析を提供しています、GlaxoSmithKline Plc, Indicus Pharma, Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Novartis AG, Otonomy Inc., Pfizer Inc., Sensorion, Sound Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Suven Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc.また、めまい治療薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/vertigo-drugs-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global vertigo drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global vertigo drugs market market 2017 - 2021 ($ million)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Peripheral vertigo - Market size and forecast 2022-2027
o Exhibit 34: Chart on Peripheral vertigo - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Peripheral vertigo - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Peripheral vertigo - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Peripheral vertigo - Year-over-year growth 2022-2027 (%)
o 6.4 Central vertigo - Market size and forecast 2022-2027
o Exhibit 38: Chart on Central vertigo - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Central vertigo - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Central vertigo - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Central vertigo - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Offline - Market size and forecast 2022-2027
o Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
o 7.4 Online - Market size and forecast 2022-2027
o Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ million)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Altamira Therapeutics Ltd.
o Exhibit 107: Altamira Therapeutics Ltd. - Overview
o Exhibit 108: Altamira Therapeutics Ltd. - Product / Service
o Exhibit 109: Altamira Therapeutics Ltd. - Key offerings
o 12.4 Amneal Pharmaceuticals Inc.
o Exhibit 110: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 111: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 112: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 113: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 114: Amneal Pharmaceuticals Inc. - Segment focus
o 12.5 Endo International Plc
o Exhibit 115: Endo International Plc - Overview
o Exhibit 116: Endo International Plc - Business segments
o Exhibit 117: Endo International Plc - Key news
o Exhibit 118: Endo International Plc - Key offerings
o Exhibit 119: Endo International Plc - Segment focus
o 12.6 Epic Pharma LLC
o Exhibit 120: Epic Pharma LLC - Overview
o Exhibit 121: Epic Pharma LLC - Product / Service
o Exhibit 122: Epic Pharma LLC - Key offerings
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 123: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 124: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 125: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 126: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 127: F. Hoffmann La Roche Ltd. - Segment focus
o 12.8 GlaxoSmithKline Plc
o Exhibit 128: GlaxoSmithKline Plc - Overview
o Exhibit 129: GlaxoSmithKline Plc - Business segments
o Exhibit 130: GlaxoSmithKline Plc - Key news
o Exhibit 131: GlaxoSmithKline Plc - Key offerings
o Exhibit 132: GlaxoSmithKline Plc - Segment focus
o 12.9 Indicus Pharma
o Exhibit 133: Indicus Pharma - Overview
o Exhibit 134: Indicus Pharma - Product / Service
o Exhibit 135: Indicus Pharma - Key offerings
o 12.10 Jubilant Pharmova Ltd.
o Exhibit 136: Jubilant Pharmova Ltd. - Overview
o Exhibit 137: Jubilant Pharmova Ltd. - Business segments
o Exhibit 138: Jubilant Pharmova Ltd. - Key news
o Exhibit 139: Jubilant Pharmova Ltd. - Key offerings
o Exhibit 140: Jubilant Pharmova Ltd. - Segment focus
o 12.11 Novartis AG
o Exhibit 141: Novartis AG - Overview
o Exhibit 142: Novartis AG - Business segments
o Exhibit 143: Novartis AG - Key offerings
o Exhibit 144: Novartis AG - Segment focus
o 12.12 Pfizer Inc.
o Exhibit 145: Pfizer Inc. - Overview
o Exhibit 146: Pfizer Inc. - Product / Service
o Exhibit 147: Pfizer Inc. - Key news
o Exhibit 148: Pfizer Inc. - Key offerings
o 12.13 Sensorion
o Exhibit 149: Sensorion - Overview
o Exhibit 150: Sensorion - Product / Service
o Exhibit 151: Sensorion - Key offerings
o 12.14 Sun Pharmaceutical Industries Ltd.
o Exhibit 152: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 153: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 154: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.15 Suven Life Sciences Ltd.
o Exhibit 155: Suven Life Sciences Ltd. - Overview
o Exhibit 156: Suven Life Sciences Ltd. - Product / Service
o Exhibit 157: Suven Life Sciences Ltd. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 158: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 159: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 162: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 163: Viatris Inc. - Overview
o Exhibit 164: Viatris Inc. - Business segments
o Exhibit 165: Viatris Inc. - Key news
o Exhibit 166: Viatris Inc. - Key offerings
o Exhibit 167: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global vertigo drugs market market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Peripheral vertigo - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Peripheral vertigo - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Peripheral vertigo - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Peripheral vertigo - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Central vertigo - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Central vertigo - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Central vertigo - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Central vertigo - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ million)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Altamira Therapeutics Ltd. - Overview
Exhibits108: Altamira Therapeutics Ltd. - Product / Service
Exhibits109: Altamira Therapeutics Ltd. - Key offerings
Exhibits110: Amneal Pharmaceuticals Inc. - Overview
Exhibits111: Amneal Pharmaceuticals Inc. - Business segments
Exhibits112: Amneal Pharmaceuticals Inc. - Key news
Exhibits113: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits114: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits115: Endo International Plc - Overview
Exhibits116: Endo International Plc - Business segments
Exhibits117: Endo International Plc - Key news
Exhibits118: Endo International Plc - Key offerings
Exhibits119: Endo International Plc - Segment focus
Exhibits120: Epic Pharma LLC - Overview
Exhibits121: Epic Pharma LLC - Product / Service
Exhibits122: Epic Pharma LLC - Key offerings
Exhibits123: F. Hoffmann La Roche Ltd. - Overview
Exhibits124: F. Hoffmann La Roche Ltd. - Business segments
Exhibits125: F. Hoffmann La Roche Ltd. - Key news
Exhibits126: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits127: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits128: GlaxoSmithKline Plc - Overview
Exhibits129: GlaxoSmithKline Plc - Business segments
Exhibits130: GlaxoSmithKline Plc - Key news
Exhibits131: GlaxoSmithKline Plc - Key offerings
Exhibits132: GlaxoSmithKline Plc - Segment focus
Exhibits133: Indicus Pharma - Overview
Exhibits134: Indicus Pharma - Product / Service
Exhibits135: Indicus Pharma - Key offerings
Exhibits136: Jubilant Pharmova Ltd. - Overview
Exhibits137: Jubilant Pharmova Ltd. - Business segments
Exhibits138: Jubilant Pharmova Ltd. - Key news
Exhibits139: Jubilant Pharmova Ltd. - Key offerings
Exhibits140: Jubilant Pharmova Ltd. - Segment focus
Exhibits141: Novartis AG - Overview
Exhibits142: Novartis AG - Business segments
Exhibits143: Novartis AG - Key offerings
Exhibits144: Novartis AG - Segment focus
Exhibits145: Pfizer Inc. - Overview
Exhibits146: Pfizer Inc. - Product / Service
Exhibits147: Pfizer Inc. - Key news
Exhibits148: Pfizer Inc. - Key offerings
Exhibits149: Sensorion - Overview
Exhibits150: Sensorion - Product / Service
Exhibits151: Sensorion - Key offerings
Exhibits152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits153: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits154: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits155: Suven Life Sciences Ltd. - Overview
Exhibits156: Suven Life Sciences Ltd. - Product / Service
Exhibits157: Suven Life Sciences Ltd. - Key offerings
Exhibits158: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits159: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits160: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits161: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits162: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits163: Viatris Inc. - Overview
Exhibits164: Viatris Inc. - Business segments
Exhibits165: Viatris Inc. - Key news
Exhibits166: Viatris Inc. - Key offerings
Exhibits167: Viatris Inc. - Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations